The Effect of Standard Cognitive-behavioral Therapy+Transcranial Alternating Current on Refractory Insomnia Disorder

Recruiting N/A Interventional Study
Insomnia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
70 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main purpose of this study is to investigate the efficacy of CBTI + transcranial alternating current (TAC) technology in the treatment of refractory insomnia and the mechanism of 'cognitive-behavioural-brain network' interactions.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Meets the diagnostic criteria for insomnia in DSM-5; 2. Pittsburgh Sleep Quality Index (PSQI) total score\>5 points; 3. Age ≥ 18 years old, with a junior high school education or above; 4. Voluntarily participate in this study and sign an informed consent form. Exclusion Cri…
Contacts

Hongxing Wang, MD & PhD

+86 13911127385

wanghongxing@xwh.ccmu.edu.cn

CONTACT